United Therapeutics (UTH) Q3 2024 Earnings Report
CH:UTH Q3 2024 EPS Results
- Actual EPS
- CHF 5.27
- Consensus EPS
- CHF 5.38
- Beat/Miss
- Missed by -CHF 0.11
- One Year Ago EPS
- CHF 4.44
CH:UTH Q3 2024 Revenue Results
- Actual Revenue
- CHF 617.70M
- Expected Revenue
- CHF 596.02M
- Beat/Miss
- Beat by +CHF 21.68M
- YoY Revenue Growth
- +22.89%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/30/2024
- Time
- Before Open
- Conference Call
- Wednesday, October 30, 2024
CH:UTH Upcoming Earnings
United Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
CH:UTH Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 4.95- | 5.91 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 5.666.00 | 5.29 | 13.42% (+0.71) | |
| May 06, 2026 | 2026 (Q1) | 5.774.80 | 5.47 | -12.22% (-0.67) | |
| Feb 25, 2026 | 2025 (Q4) | 5.886.35 | 5.11 | 24.39% (+1.25) | |
| Oct 29, 2025 | 2025 (Q3) | 6.045.91 | 5.27 | 12.05% (+0.64) | |
| Jul 30, 2025 | 2025 (Q2) | 6.025.29 | 4.83 | 9.57% (+0.46) | |
| Apr 30, 2025 | 2025 (Q1) | 5.525.47 | 5.09 | 7.46% (+0.38) | |
| Feb 26, 2025 | 2024 (Q4) | 5.285.11 | 3.6 | 41.97% (+1.51) | |
| Oct 30, 2024 | 2024 (Q3) | 5.385.27 | 4.44 | 18.77% (+0.83) | |
| Jul 31, 2024 | 2024 (Q2) | 5.374.83 | 4.32 | 11.64% (+0.50) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
